MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elferink, C. J.
Right arrow Articles by Levine, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elferink, C. J.
Right arrow Articles by Levine, A.

Vol. 59, Issue 4, 664-673, April 2001

Maximal Aryl Hydrocarbon Receptor Activity Depends on an Interaction with the Retinoblastoma Protein

Cornelis J. Elferink, Nie-Lin Ge,1 and Aviva Levine

Institute of Chemical Toxicology, Wayne State University, Detroit, Michigan

The aryl hydrocarbon receptor (AhR) belongs to the basic helix-loop-helix/periodicity/AhR nuclear translocator/simple-minded (Per-Arnt-Sim) family of transcription factors that regulate critical functions during development and tissue homeostasis. Within this family, the AhR is the only member conditionally activated in response to ligand binding, typified by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). We recently demonstrated that the AhR interacts with the retinoblastoma protein (pRb). This report presents evidence that a LXCXE motif in the AhR protein confers pRb binding, which is necessary for maximal TCDD induced G1 arrest in rat 5L hepatoma cells. The data support a mechanism whereby pRb seems to regulate G1 cell cycle progression distinct from the direct repression of E2F-mediated transcription. Furthermore, the results indicate that the AhR-pRb interaction regulates TCDD induction of CYP1A1, suggesting that pRb may be a general AhR coactivator.


1 Current address: Laboratory of Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.


Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
E. Wincent, N. Amini, S. Luecke, H. Glatt, J. Bergman, C. Crescenzi, A. Rannug, and U. Rannug
The Suggested Physiologic Aryl Hydrocarbon Receptor Activator and Cytochrome P4501 Substrate 6-Formylindolo[3,2-b]carbazole Is Present in Humans
J. Biol. Chem., January 30, 2009; 284(5): 2690 - 2696.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Z. Han, Y. Miwa, H. Obikane, M. Mitsumata, F. Takahashi-Yanaga, S. Morimoto, and T. Sasaguri
Aryl hydrocarbon receptor mediates laminar fluid shear stress-induced CYP1A1 activation and cell cycle arrest in vascular endothelial cells
Cardiovasc Res, March 1, 2008; 77(4): 809 - 818.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
H. Sarioglu, S. Brandner, M. Haberger, C. Jacobsen, J. Lichtmannegger, M. Wormke, and U. Andrae
Analysis of 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced Proteome Changes in 5L Rat Hepatoma Cells Reveals Novel Targets of Dioxin Action Including the Mitochondrial Apoptosis Regulator VDAC2
Mol. Cell. Proteomics, February 1, 2008; 7(2): 394 - 410.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. Singhal, K. Shankar, T. M. Badger, and M. J. Ronis
Estrogenic status modulates aryl hydrocarbon receptor--mediated hepatic gene expression and carcinogenicity
Carcinogenesis, February 1, 2008; 29(2): 227 - 236.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
X. Chang, Y. Fan, S. Karyala, S. Schwemberger, C. R. Tomlinson, M. A. Sartor, and A. Puga
Ligand-Independent Regulation of Transforming Growth Factor {beta}1 Expression and Cell Cycle Progression by the Aryl Hydrocarbon Receptor
Mol. Cell. Biol., September 1, 2007; 27(17): 6127 - 6139.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. A. Mitchell, C. A. Lockhart, G. Huang, and C. J. Elferink
Sustained Aryl Hydrocarbon Receptor Activity Attenuates Liver Regeneration
Mol. Pharmacol., July 1, 2006; 70(1): 163 - 170.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. A. Lavine, A. J. Rowatt, T. Klimova, A. J. Whitington, E. Dengler, C. Beck, and W. H. Powell
Aryl Hydrocarbon Receptors in the Frog Xenopus laevis: Two AhR1 Paralogs Exhibit Low Affinity for 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD)
Toxicol. Sci., November 1, 2005; 88(1): 60 - 72.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
P Pocar, B Fischer, T Klonisch, and S Hombach-Klonisch
Molecular interactions of the aryl hydrocarbon receptor and its biological and toxicological relevance for reproduction
Reproduction, April 1, 2005; 129(4): 379 - 389.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. A. Bonzo, S. Chen, A. Galijatovic, and R. H. Tukey
Arsenite Inhibition of CYP1A1 Induction by 2,3,7,8-Tetrachlorodibenzo-p-dioxin Is Independent of Cell Cycle Arrest
Mol. Pharmacol., April 1, 2005; 67(4): 1247 - 1256.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K.-T. Park, K. A. Mitchell, G. Huang, and C. J. Elferink
The Aryl Hydrocarbon Receptor Predisposes Hepatocytes to Fas-Mediated Apoptosis
Mol. Pharmacol., March 1, 2005; 67(3): 612 - 622.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Huang and C. J. Elferink
Multiple Mechanisms Are Involved in Ah Receptor-Mediated Cell Cycle Arrest
Mol. Pharmacol., January 1, 2005; 67(1): 88 - 96.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Marlowe, E. S. Knudsen, S. Schwemberger, and A. Puga
The Aryl Hydrocarbon Receptor Displaces p300 from E2F-dependent Promoters and Represses S Phase-specific Gene Expression
J. Biol. Chem., July 9, 2004; 279(28): 29013 - 29022.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Ito, S.-i. Tsukumo, N. Suzuki, H. Motohashi, M. Yamamoto, Y. Fujii-Kuriyama, J. Mimura, T.-M. Lin, R. E. Peterson, C. Tohyama, et al.
A Constitutively Active Arylhydrocarbon Receptor Induces Growth Inhibition of Jurkat T Cells through Changes in the Expression of Genes Related to Apoptosis and Cell Cycle Arrest
J. Biol. Chem., June 11, 2004; 279(24): 25204 - 25210.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
B. Santiago-Josefat, S. Mulero-Navarro, S. L. Dallas, and P. M. Fernandez-Salguero
Overexpression of latent transforming growth factor-{beta} binding protein 1 (LTBP-1) in dioxin receptor-null mouse embryo fibroblasts
J. Cell Sci., February 22, 2004; 117(6): 849 - 859.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Levine-Fridman, L. Chen, and C. J. Elferink
Cytochrome P4501A1 Promotes G1 Phase Cell Cycle Progression by Controlling Aryl Hydrocarbon Receptor Activity
Mol. Pharmacol., February 1, 2004; 65(2): 461 - 469.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
R. Elkon, C. Linhart, R. Sharan, R. Shamir, and Y. Shiloh
Genome-Wide In Silico Identification of Transcriptional Regulators Controlling the Cell Cycle in Human Cells
Genome Res., May 1, 2003; 13(5): 773 - 780.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. T. Landi, P. A. Bertazzi, A. Baccarelli, D. Consonni, S. Masten, G. Lucier, P. Mocarelli, L. Needham, N. Caporaso, and J. Grassman
TCDD-mediated alterations in the AhR-dependent pathway in Seveso, Italy, 20 years after the accident
Carcinogenesis, April 1, 2003; 24(4): 673 - 680.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. Hannenhalli and S. Levy
Predicting transcription factor synergism
Nucleic Acids Res., October 1, 2002; 30(19): 4278 - 4284.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. V. Beischlag, S. Wang, D. W. Rose, J. Torchia, S. Reisz-Porszasz, K. Muhammad, W. E. Nelson, M. R. Probst, M. G. Rosenfeld, and O. Hankinson
Recruitment of the NCoA/SRC-1/p160 Family of Transcriptional Coactivators by the Aryl Hydrocarbon Receptor/Aryl Hydrocarbon Receptor Nuclear Translocator Complex
Mol. Cell. Biol., June 15, 2002; 22(12): 4319 - 4333.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics